FDA proposes downgrading drug color additive changes to CBE-30
Regulatory NewsJoanne S. Eglovitch
Chemistry, Manufacturing and Controls (CMC)ExcipientsGuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)